Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19
Authors
Keywords
ARDS, COVID-19, Inflammation, p38 MAP kinase, SARS-CoV-2
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 221, Issue -, Pages 107745
Publisher
Elsevier BV
Online
2020-11-12
DOI
10.1016/j.pharmthera.2020.107745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preface
- (2020) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- The p38 Pathway: From Biology to Cancer Therapy
- (2020) Adrián Martínez-Limón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- (2020) Betsy J. Barnes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly
- (2020) Roel P. H. De Maeyer et al. NATURE IMMUNOLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
- (2020) Laure Wynants et al. BMJ-British Medical Journal
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- (2020) Mehdi Bouhaddou et al. CELL
- Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
- (2020) Mark Roschewski et al. Science Immunology
- Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19
- (2020) Jun Wang et al. Frontiers in Immunology
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNFαwith Minimal Systemic Exposure
- (2018) Rikard Pehrson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
- (2018) Marie Fisk et al. PLoS One
- The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
- (2018) Naimish Patel et al. International Journal of Chronic Obstructive Pulmonary Disease
- Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
- (2017) Steven Pascoe et al. RESPIRATORY MEDICINE
- Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection
- (2017) Carolin Klemm et al. Scientific Reports
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease
- (2016) P. S. Pillai et al. SCIENCE
- Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2
- (2015) Dauren Alimbetov et al. BIOGERONTOLOGY
- Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice
- (2015) Lifang Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
- (2015) Jason D. Christie et al. CRITICAL CARE MEDICINE
- Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
- (2014) Marie Fisk et al. American Journal of Cardiovascular Drugs
- Age-related activation of MKK/p38/NF-κB signaling pathway in lung: From mouse to human
- (2014) Xiaoxia Ren et al. EXPERIMENTAL GERONTOLOGY
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection
- (2013) Yvonne Börgeling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
- (2013) William MacNee et al. THORAX
- Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
- (2013) Henrik Watz et al. Lancet Respiratory Medicine
- Impaired secretion of interferons by dendritic cells from aged subjects to influenza
- (2012) Sangeetha Prakash et al. AGE
- Inhibition of p38 Mitogen-Activated Protein Kinase Improves Nitric Oxide–Mediated Vasodilatation and Reduces Inflammation in Hypercholesterolemia
- (2011) Joseph Cheriyan et al. CIRCULATION
- p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
- (2011) Adam Freund et al. EMBO JOURNAL
- Impaired Interferon Signaling in Dendritic Cells From Older Donors Infected In Vitro With West Nile Virus
- (2011) Feng Qian et al. JOURNAL OF INFECTIOUS DISEASES
- A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
- (2011) MARK C. GENOVESE et al. JOURNAL OF RHEUMATOLOGY
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway
- (2008) Vijay Koka et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started